Contract notice: Pharmaceutical products Tender, Germany - 14996485

Procurement Summary

Country : Germany

Summary : Contract notice: Pharmaceutical products

Deadline : 05 Jul 2019

Other Information

Notice Type : Tender

TOT Ref.No.: 14996485

Document Ref. No. : 278565-2017

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : DAK-GESUNDHEIT
Office Name: DAK-Gesundheit
Address: Nagelsweg 27-31
Town: Hamburg
Postal Code: 20097


Phone: +49 402396-2682
Fax: +49 402396-3661
Germany
Email :vergabestelle@dak.de
URL :www.dak.de

Tender Details

Object of the contract
Pharmaceutical products

Description: Contract notice: Pharmaceutical products

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: Lowest price
CPV code: 33600000, 33600000
CPV Description: Pharmaceutical products.

Completion of a non-exclusive discount agreement pursuant to - 130a para. 8 SGB V to the active substance Paricalcitol (only DFL), ATC N02BG07, for the time 1.9.2017 31.8.2019 .-- Reference Number: 1001848 - Paricalcitol (DFL only) - 130a para. 8 SGB V allows health insurance companies and pharmaceutical companies to take out framework agreements for the benefit of statutory health insurance fundsMedicinal products. With regard to the statutory provisions governing the award of public contracts, a regular process of drug-related, so-called tendering procedure takes place according to the regulations of the fourth part of the GWB by the DAK-G. For medicinal products to be designated by the tenderer in Annex 2 to the contract to the active substance paricalcitol (Only DFL), ATC N02BG07, the DAK-G intends to conclude drug discounts with the latest pharmaceutical sales contracts with the most possible pharmaceutical companies. A discount agreement within the scope of the admission model for the above- Active substance enters into force for the first time on 1.9.2017 and ends on 31.8.2019. It ends automatically with the entry into force automaticallyN of the exclusive contract.

The DAK-G assumes that this procedure does not come within the scope of the antitrust law because of the lack of a selection decision and the non-discriminatory accessibility of all pharmaceutical companies. It shall terminate automatically, with the entry into force of the exclusive agreement to Paricalcitol (DFL only), ATC N02BG07, in FoOf a procurement procedure under the regulations of Part Four of the GWB with one or more contracting parties. In order to meet the diversity of the potential contract partners within the framework of the licensing model, each pharmaceutical company is allowed to conclude a framework contract at any time and under the same conditions during the contract period. The inventors'Order documents are available via the online portal www.dtvp.de/center under the I.3., The complete and timely transmission of the following proofs / declarations / attachments (available for download under the UntHe I.3. ) To the following contact person at DAK-G:

1. Letter of Offer

2nd Current proof of entry in the professional or commercial register (see III.1.1.)

3. Declaration by the company (Annex A1) that none of the exclusion criteria is in accordance with -- 123, 124 GWB (see III.1.1.). Declare that for those medicines for whichThe applicant wishes to conclude a contract in the context of this procedure, has an authorization under the law on medicinal products, and that the tenderer is entitled to sell (Annex A2) (see III.1.1. Declaration by the company that the statutory provisions on the minimum wage and tariff refusal are respected and complied with (Annex A3) (see III.1.1.). Recognition of the-Contractual stipulations of the DAK health, in particular also of the given discounts by the signing of the contract stamped with a company stamp (2 times in the original) by the interested party at the designated place. The completed enclosures 1 and 2 to the contract (2-fold in the original). The interested party has the drugs to the above mentioned. Active substance, whichShould be made. Effective Praequalifikationsbescheid the DAK health (see III.1.1 and III.1.2...)

The documents must be submitted by post to:.

DAK health, Henri Affinass (0032 50) Nagelsweg 27-31, 20097 Hamburg.

Furthermore, the system 2 send simultaneously am_rabattvertraege@dak.de as an Excel file to the mail address. Contracts within the scope of this model and to the above.-Active substance will be concluded for the first time with effect from 1 July 2017 and end on 31.8.2019. Interested parties wishing to become contractors on this date have the documents to be submitted by the 5th of the previous month, Position. This is due to the timely access to DAK health. Later accessions are possible at any time. At the end of the termOf the Treaty to the 1st or 15th of the following month, the above- Documents, irrespective of the desired accession, of the DAK health up to the 5th of the previous month. This also applies to the timely access to the DAK-G. Example: The bidding requested by the bidder is to take place on 15.7.20xx (follow-up), the documents must be submitted by 5.6.20xx (VOrmonat). Note: The publication is done here using the form for open procedures. As already made clear, this is not such a notice had to be used for technical reasons, since there is no suitable form for approval procedure. Current proof of entry in the professional or commercial register (nMore than 6 months after dispatch) in accordance with the legislation of the country in which the company is resident, Eg current commercial register extract; Copy is sufficient.

2. Declaration by the company that none of the exclusion criteria is in accordance with -- 123, 124 GWB. To this end, the A1 is to be signed, to be stamped with the company stamp and to be submitted in the original. eThat a medicinal product is authorized for medicinal products for which the interested party wishes to conclude a contract under this procedure and that the tenderer is entitled to distribute it at the start of the contract (Annex A2) (see III.1.1.), Declaration by the company that the legal requirements for the minimum wage and the tariff refusal are respected-And are complied with (Annex A3). DAK Health has published a so-called pre-qualification procedure for pharmaceutical companies for the simplified participation in future drug discounts (via the European Notification Platform) (EU Notice 2015)/ S 105-190319 of 3, 6, 2015). If the bidder has received an effective pre-qualification notice from the DAK health in good time before submission of the dossier, he needs the company-specific suitability proofs (proof of the entry in the professional or commercial register, the company's own declaration that none of the exclusion criteria according to -- 123, 124 GWB is availableCertificate of the statutory health insurance fund) with a copy and a copy of the prequalification certificate. Annex A2 is to be added in all cases. The pre-qualification certificate for DAK health is also used as proof for open-house DAK health procedures, irrespective of the value of the orderFor which the interested party wishes to conclude the contract in the context of this procedure, has an authorization under the law on medicinal products and that the tenderer is entitled to sell it at the start of the contract. For this purpose, the attachment A2 has to be signed, stamped with the company stamp and submitted in the original. The DAK health has a so-called Praeq over the European notation platformProcedure for pharmaceutical companies for simplified participation in future drug reimbursements (EU Notice 2015 / S 105-190319 of 3.6.2015). If the bidder has received an effective pre-qualification notice from the DAK health in good time before submission of the dossier, he needs the company-specific suitability proofE (proof of entry in the professional or trade register, declaration of the company's own declaration that none of the exclusion criteria according to -- 123, 124 GWB is present, certificate of harmlessness of the statutory health insurance fund) in copying with the reference and appending of the prequalification certificate. Annex A2 is to be added in all cases. The Prequalification Notice deR DAK health also serves as a proof for open-house procedures of DAK health.

The contract documents can also be sent by e-mail to the address given under I.1. Must be requested. The tender documents will then be sent by e-mail. Questions and notes on the tender documents are sent electronically (by means of bidder communication)Via the award portal www.dtvp.de) or in individual cases by e-mail or in writing (by fax or letter) to the persons mentioned under I.1. Contact point. They are to be formulated in German. Responses will be made available in anonymous form to all contractors who requested the registration documents by means of a registration. The-Answers to the entrepreneurs by means of bidder communication via the public procurement portal www.dtvp.de. Companies who have downloaded the tender documents without registration must, on their own responsibility, pursue the further communication and, if necessary, This publication is not intended to be used as a referenceAward of a public contract within the meaning of the Public Procurement Directive 2014/24 / EU of the European Parliament and of the Council, In order to ensure the widest degree of transparency for the intended

contract conclusion, the supplement is published in the Official Journal of the European Union. In the absence of a corresponding publicationNgsformulars, the contract notice shall be used. The resulting conceptual specifications, such as, for example, the procedure name "Open Procedure", are solely due to the use of this publication form and to the publishing platformAre not linked.

Announcement ID: CXP4YM5YE7X.


Internet address (URL): www.dak.de
Directive: Classical Directive (2014/24/EU)

Documents

 Tender Notice